-
SAN DIEGO, California When introduced to the U.S. market in the summer of 1998, many industry observers expected that transmyocardial revascularization (TMR) would be adopted rapidly by the cardiac surgery community.
-
-
A third player has entered the drug-eluting stent sector in Europe, though the company claims it was really the second firm to earn the CE mark. While that may be the case, the real question may be the devices speed of entry to U.S. launch.
-
George Daniloff, MD, PhD, has been named general manager and vice president of research and development of the California facility of Angiotech Pharmaceuticals (Vancouver, British Columbia).
-
A Medicare advisory panel recommendation to cover implantable cardioverter defibrillators (ICDs) could be a major victory for companies such as Guidant (Indianapolis, Indiana), Medtronic (Minneapolis, Minnesota) and St. Jude Medical (St. Paul, Minnesota).
-
Digital Angel (South St. Paul, Minnesota) said it is working closely with the University of California at Riverside School of Engineering to accelerate the integration of medical and environmental biosensor technologies into its expanding line of wireless communications devices.
-
A team of French physicians said it has proof of principle that autologous cell therapy is a viable treatment for myocardial infarction.
-
SAN DIEGO, California The 39th annual meeting of the Society of Thoracic Surgeons (STS; Chicago, Illinois), held here in early February, along with the STS/AATS Tech-Con conference, provided a window to the changing role of surgery in the treatment of cardiovascular disease.
-
More than $800 million in increased spending for hospitals is included in the omnibus spending bill signed in late February by President Bush.
-
In what is likely to be welcome news for hospitals burdened with the cost of caring for undocumented aliens, federal legislation has been introduced that would reimburse providers for the cost of emergency care for these individuals.
